Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Espino-Hernandez

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Medical Research Methodology|May 17, 2011
Bayesian adjustment for measurement error in continuous exposures in an individually matched case-control studyGabriela Espino-Hernandez, Paul Gustafson, Igor Burstyn
Canadian Journal of Kidney Health and Disease|March 28, 2018
The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular DiseasesSean Barbour, Clifford Lo, Gabriela Espino-Hernandez, et al.
Canadian Journal of Kidney Health and Disease|February 21, 2022
Femoral Arteriovenous Grafts for Hemodialysis: Retrospective Comparison With Upper Extremity Grafts and FistulasChance Dumaine, Gabriela Espino-Hernandez, Alexandra Romann, et al.
Canadian Journal of Kidney Health and Disease|May 20, 2020
Prescription Patterns in Dialysis Patients: Differences Between Hemodialysis and Peritoneal Dialysis Patients and Opportunities for DeprescriptionJudith G Marin, Laura Beresford, Clifford Lo, et al.
Clinical Kidney Journal|April 11, 2015
The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologistsSean Barbour, Monica Beaulieu, Jagbir Gill, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practiceSean Barbour, Clifford Lo, Gabriela Espino-Hernandez, et al.
Kidney International|August 20, 2015
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritisSean J Barbour, Daniel C Cattran, Gabriela Espino-Hernandez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2018
Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic careSimon Sawhney, Monica Beaulieu, Corri Black, et al.
Kidney International|January 14, 2016
The MEST score provides earlier risk prediction in lgA nephropathySean J Barbour, Gabriela Espino-Hernandez, Heather N Reich, et al.
CMAJ Open|December 22, 2021
Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive studyAnna M Chiarelli, Meghan J Walker, Gabriela Espino-Hernandez, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Medical Research Methodology|May 17, 2011
Bayesian adjustment for measurement error in continuous exposures in an individually matched case-control studyGabriela Espino-Hernandez, Paul Gustafson, Igor Burstyn
Canadian Journal of Kidney Health and Disease|March 28, 2018
The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular DiseasesSean Barbour, Clifford Lo, Gabriela Espino-Hernandez, et al.
Canadian Journal of Kidney Health and Disease|February 21, 2022
Femoral Arteriovenous Grafts for Hemodialysis: Retrospective Comparison With Upper Extremity Grafts and FistulasChance Dumaine, Gabriela Espino-Hernandez, Alexandra Romann, et al.
Canadian Journal of Kidney Health and Disease|May 20, 2020
Prescription Patterns in Dialysis Patients: Differences Between Hemodialysis and Peritoneal Dialysis Patients and Opportunities for DeprescriptionJudith G Marin, Laura Beresford, Clifford Lo, et al.
Clinical Kidney Journal|April 11, 2015
The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologistsSean Barbour, Monica Beaulieu, Jagbir Gill, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practiceSean Barbour, Clifford Lo, Gabriela Espino-Hernandez, et al.
Kidney International|August 20, 2015
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritisSean J Barbour, Daniel C Cattran, Gabriela Espino-Hernandez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2018
Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic careSimon Sawhney, Monica Beaulieu, Corri Black, et al.
Kidney International|January 14, 2016
The MEST score provides earlier risk prediction in lgA nephropathySean J Barbour, Gabriela Espino-Hernandez, Heather N Reich, et al.
CMAJ Open|December 22, 2021
Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive studyAnna M Chiarelli, Meghan J Walker, Gabriela Espino-Hernandez, et al.
Pageof 2